Abhishesh Kumar Mehata

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

Nanomedicine (London, England)

Pharmaceutics

Future virology

Pharmaceuticals (Basel, Switzerland)

Indian Institute of Technology BHU

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indian Institute of Technology BHU

India

Research Scholar :: Pharmaceutical Engineering and Technology

Publications

Abhishesh Kumar Mehata, Aseem Setia, Vikas, Ankit Kumar Malik, Rym Hassani, Hamad Ghaleb Dailah, Hassan A Alhazmi, Ahmed A Albarraq, Syam Mohan, Madaswamy S Muthu
Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future. Pharmaceutics 15 (3) (2023)
Abhishesh Kumar Mehata, null Vikas, Matte Kasi Viswanadh, Madaswamy S Muthu
Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation. Nanomedicine (London, England) (2023)
Abhishesh Kumar Mehata, Aseem Setia, Vikas, Ankit Kumar Malik, Rym Hassani, Hamad Ghaleb Dailah, Hassan A Alhazmi, Ahmed A Albarraq, Syam Mohan, Madaswamy S Muthu
Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future. Pharmaceutics 15 (3) (2023)
Abhishesh Kumar Mehata, Niharika Gupta, Madaswamy S Muthu
Exosomes as a novel nanomedicine platform for personalized triple-negative breast cancer therapy. Nanomedicine (London, England) (2023)
Abhishesh Kumar Mehata, Aseem Setia, Vikas, Ankit Kumar Malik, Rym Hassani, Hamad Ghaleb Dailah, Hassan A Alhazmi, Ahmed A Albarraq, Syam Mohan, Madaswamy S Muthu
Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future. Pharmaceutics 15 (3) (2023)
Chandrashekhar Singh, Abhishesh Kumar Mehata, Vishnu Priya, Ankit Kumar Malik, Aseem Setia, M Nikitha Lakshmi Suseela, null Vikas, Patharaj Gokul, null Samridhi, Sanjeev K Singh, Madaswamy S Muthu
Bimetallic Au-Ag Nanoparticles: Advanced Nanotechnology for Tackling Antimicrobial Resistance. Molecules (Basel, Switzerland) 27 (20) (2022)
null Vikas, Hemendra Kumar Sahu, Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu
Dual-receptor-targeted nanomedicines: emerging trends and advances in lung cancer therapeutics. Nanomedicine (London, England) 17 (19) (2022)
Natasha Manners, Vishnu Priya, Abhishesh Kumar Mehata, Manoj Rawat, Syam Mohan, Hafiz A Makeen, Mohammed Albratty, Ali Albarrati, Abdulkarim M Meraya, Madaswamy S Muthu
Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, null Vikas, Madaswamy S Muthu
Harnessing immunological targets for COVID-19 immunotherapy. Future virology (2021)
Vishnu Priya, Matte Kasi Viswanadh, Abhishesh Kumar Mehata, Dharmendra Jain, Sanjeev K Singh, Madaswamy S Muthu
Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis. Nanomedicine (London, England) 16 (13) (2021)
Matte Kasi Viswanadh, null Vikas, Abhishek Jha, Sandeep Kumar Reddy Adena, Abhishesh Kumar Mehata, Vishnu Priya, Kaushik Neogi, Suruchi Poddar, Sanjeev Kumar Mahto, Madaswamy S Muthu
Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy. Nanomedicine (London, England) 15 (24) (2020)

Abhishesh Kumar Mehata.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Abhishesh Kumar Mehata